Wealthfront Advisers LLC significantly increased its stake in Colgate-Palmolive (CL) by 30.9%, acquiring 207,417 shares valued at $16.58 million. This move contributes to a robust total institutional ownership of 80.41% in the consumer goods giant. The increased investment follows Colgate-Palmolive's strong fourth-quarter earnings report, which surpassed consensus estimates. Financial analysts maintain a "Moderate Buy" rating for CL, setting an average target price of $94.47. This confluence of increased institutional confidence, strong financial performance, and positive analyst sentiment underscores a bullish outlook for the stock.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis